Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) insider Keith J. Sullivan sold 8,000 shares of the company’s stock in a transaction on Tuesday, October 4th. The shares were sold at an average price of $38.84, for a total transaction of $310,720.00. Following the completion of the transaction, the insider now owns 82,591 shares in the company, valued at $3,207,834.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) opened at 40.42 on Wednesday. Zeltiq Aesthetics Inc. has a 52-week low of $18.41 and a 52-week high of $41.48. The company has a market cap of $1.60 billion, a PE ratio of 60.78 and a beta of 0.79. The company’s 50-day moving average is $38.95 and its 200 day moving average is $32.17.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last issued its quarterly earnings data on Monday, August 8th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.07. Zeltiq Aesthetics had a net margin of 9.54% and a negative return on equity of 9.90%. The company had revenue of $89.50 million for the quarter, compared to the consensus estimate of $79.68 million. During the same quarter last year, the business posted $0.03 earnings per share. Zeltiq Aesthetics’s revenue was up 38.9% on a year-over-year basis. On average, analysts anticipate that Zeltiq Aesthetics Inc. will post ($0.13) EPS for the current year.
A number of institutional investors have recently modified their holdings of ZLTQ. PineBridge Investments L.P. boosted its position in shares of Zeltiq Aesthetics by 4.9% in the second quarter. PineBridge Investments L.P. now owns 4,103 shares of the company’s stock valued at $112,000 after buying an additional 193 shares during the period. Teacher Retirement System of Texas boosted its position in shares of Zeltiq Aesthetics by 26.9% in the second quarter. Teacher Retirement System of Texas now owns 4,884 shares of the company’s stock valued at $133,000 after buying an additional 1,036 shares during the period. Legal & General Group Plc boosted its position in shares of Zeltiq Aesthetics by 1.7% in the first quarter. Legal & General Group Plc now owns 4,963 shares of the company’s stock valued at $134,000 after buying an additional 83 shares during the period. First Mercantile Trust Co. bought a new position in shares of Zeltiq Aesthetics during the third quarter valued at $204,000. Finally, Riverhead Capital Management LLC boosted its position in shares of Zeltiq Aesthetics by 492.3% in the second quarter. Riverhead Capital Management LLC now owns 5,775 shares of the company’s stock valued at $289,000 after buying an additional 4,800 shares during the period.
A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Zeltiq Aesthetics from a “hold” rating to a “sell” rating in a research report on Thursday, July 14th. Leerink Swann reissued an “outperform” rating and issued a $48.00 target price (up previously from $43.00) on shares of Zeltiq Aesthetics in a research report on Thursday, August 11th. Brean Capital set a $39.00 target price on shares of Zeltiq Aesthetics and gave the company a “buy” rating in a research report on Tuesday, August 9th. JPMorgan Chase & Co. reissued a “hold” rating and issued a $35.00 target price (up previously from $27.00) on shares of Zeltiq Aesthetics in a research report on Tuesday, August 9th. Finally, Stifel Nicolaus boosted their target price on shares of Zeltiq Aesthetics from $38.00 to $52.00 and gave the company a “buy” rating in a research report on Wednesday, September 21st. Three research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $39.89.
Zeltiq Aesthetics Company Profile
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
Receive News & Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.